Gold prices outlook for 2026: Deutsche Bank sets new target

Feiner Gary has sold shares of VirnetX (VHC) valued at $42,562, as reported by Investing.com. This transaction reflects personal financial decisions made by Gary regarding his stake in the company, which specializes in secure communications solutions.

QuantumScape's Chief Legal Officer, McCarthy, has sold shares worth $894,000, a transaction reported by Investing.com. This sale reflects McCarthy's financial decisions regarding his stake in the company, which is focused on developing solid-state battery technology for electric vehicles.

Farquhar Scott, a director at Atlassian Corporation, has sold shares worth $1.13 million in the company, as reported by Investing.com. This transaction highlights Scott's ongoing financial maneuvers regarding his stake in Atlassian, a firm recognized for its collaboration software solutions.

Atlassian CEO Mike Cannon-Brookes has sold $1.13 million worth of stock in the company, a move reported by Investing.com. This transaction reflects Cannon-Brookes' financial decisions regarding his stake in Atlassian, which is known for its collaboration and productivity software solutions.

Bank of America (BofA) has raised its GDP estimates for Japan, indicating a positive outlook for the country's economic growth. This adjustment comes amid expectations of gradual tightening by the Bank of Japan (BOJ), reflecting a shift in monetary policy as inflationary pressures persist.

New Zealand's housing market is experiencing significant challenges, leading to doubts about reliable investment strategies and negatively impacting the economy. The ongoing funk in the housing sector raises concerns about future growth and stability in the market.

Cathay General Bancorp's executive chairman has sold $362,842 worth of stock, a transaction reported by Investing.com. This sale reflects the chairman's financial decisions regarding his stake in the company, which operates in the banking sector.

Alignment Healthcare director Konowiecki has sold $475,000 worth of stock, a transaction reported by Investing.com. This sale reflects Konowiecki's financial decisions regarding his stake in the company, which operates in the healthcare sector.